SCHEMBL4157559

SCHEMBL4157559

CCNCc1ccc(NC(=O)c2ccc(Cc3cc(Cl)cc4cc(C(C)C)oc34)o2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 10/20 0.56
ALDH1A1 P00352 4/20 0.40
TP53 P04637 3/20 0.40
LMNA P02545 2/20 0.40
HPGD P15428 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 3/20 0.38
PTGER3 P43115 1/20 0.38
POLB P06746 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
MCL1 Q07820 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4161533 0.99 PTGER1 (0.55) PTGER1ALDH1A1TP53LMNAHPGD
SCHEMBL4162628 0.89 PTGER1 (0.55) PTGER1ALDH1A1TP53LMNAHPGD
SCHEMBL4160757 0.88 PTGER1 (0.53) PTGER1ALDH1A1TP53LMNAHPGD
SCHEMBL4167685 0.84 PTGER1 (0.55) PTGER1ALDH1A1TP53LMNAHPGD
SCHEMBL4157725 0.83 PTGER1 (0.54) PTGER1ALDH1A1TP53LMNAHPGD
Hydrochloric Acid SCHEMBL4162562 0.82 PTGER1 (0.53) PTGER1ALDH1A1TP53LMNAHPGD
SCHEMBL4164383 0.81 MEN1 (0.49) PTGER1ALDH1A1NPC1SMN1; SMN2CYP1A2
SCHEMBL4167783 0.81 PTGER1 (0.52) PTGER1ALDH1A1TP53LMNAHPGD
Hydrochloric Acid SCHEMBL4168845 0.81 PTGER1 (0.51) PTGER1ALDH1A1TP53LMNAHPGD
SCHEMBL4165897 0.80 PTGER1 (0.49) PTGER1ALDH1A1SMN1; SMN2CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099169-A1 Benzofuran Compounds As EP1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2009-04-16 US claimed
US-20090099169-A1 Benzofuran Compounds As EP1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2009-04-16 US disclosed
US-20090099169-A1 Benzofuran Compounds As EP1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2009-04-16 US disclosed
WO-2007113289-A1 BENZOFURAN COMPOUNDS AS EP1 RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099169-A1 Benzofuran Compounds As EP1 Receptor Antagonists PTGER1, PTGER2, PTGER3 PTGER1 1/4885ALDH1A1 337/4885TP53 4114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.